Counterpoint: pharmacogenetic-based initial dosing of warfarin: not ready for prime time.

Clinical chemistry

Volumn 55, Issue 4, 2009, Pages 712-714

  Eby, Charles S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

CHEMISTRY; DOSE RESPONSE; HUMAN; NOTE; PHARMACOGENETICS; RANDOMIZED CONTROLLED TRIAL;

DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHARMACOGENETICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WARFARIN;

EID: 64149087950     PISSN: None     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.115972     Document Type: Note

References (0)